Results 101 to 110 of about 26,123,489 (353)

Varicella Breakthrough Infection and Vaccine Effectiveness in Taiwan

, 2012
We performed this nationwide retrospective investigation among the recipients of varicella vaccine to evaluate the breakthrough varicella infection rate, factors associated with breakthrough infection and the vaccine effectiveness.
HUANG, WEN-CHAN;HUANG, LI-MIN;CHANG, I-SHOU;TSAI, FANG-YU;CHANG, LUAN-YIN, 黃文嬋;黃立民;張憶壽;蔡芳榆;張鑾英   +1 more
core   +1 more source

Vaccine Innovation Conference 2017 [PDF]

, 2017
Proceedings from the Vaccine Innovation Conference 2017, held May 10, 2017, at Hyatt Regency Hotel, Montréal, QC, Canada, Presented by: Vaccine Industry ...
Committee, Vaccine Industry, Vaccine Industry Committee   +1 more
core   +1 more source

Immunoinformatics-Aided Analysis of RSV Fusion and Attachment Glycoproteins to Design a Potent Multi-Epitope Vaccine

, 2022
Respiratory syncytial virus (RSV) usually causes respiratory tract infections of upper airways in infants and young children. Despite recent medical advances, no approved vaccine is available to control RSV infections.
Shahkaar Aziz, Aziz, Shahkaar, Waheed, Yasir, Yasir Waheed, Hamza Arshad Dar, Fahad Nasser Almajhdi, Dar, Hamza Arshad, Almajhdi, Fahad Nasser   +7 more
core   +1 more source

Delivery of DNA‐encoded vaccines and proteins in mice using cutaneous suction‐mediated transfection

FEBS Open Bio, EarlyView.
Cutaneous suction‐mediated transfection in mice for delivery of DNA‐encoded vaccines and proteins. A critical limitation of DNA vaccines and other therapeutics is transfection in vivo to produce the encoded antigens or therapeutic proteins. Cutaneous suction‐based methods have demonstrated effectiveness in many animal models and have been successfully ...
Emran O. Lallow, Isabel Brandtjen, Yaxin Mo, Melissa Gulley, Louis Osorio, Sagar Kudchodkar, Nandita C. Jhumur, Christine C. Roberts, Lisa K. Denzin, David I. Shreiber, Biju Parekkadan, Hao Lin, Joel N. Maslow   +12 more
wiley   +1 more source

Exploring the nuclear proteins, viral capsid protein, and early antigen protein using immunoinformatic and molecular modeling approaches to design a vaccine candidate against Epstein Barr virus

Scientific Reports
The available Epstein Barr virus vaccine has tirelessly harnessed the gp350 glycoprotein as its target epitope, but the result has not been preventive. Right here, we designed a global multi-epitope vaccine for EBV; with special attention to making sure ...
Elijah Kolawole Oladipo, Taiwo Ooreoluwa Ojo, Oluwabamise Emmanuel Elegbeleye, Olawale Quadri Bolaji, Moyosoluwa Precious Oyewole, Abdeen Tunde Ogunlana, Emmanuel Obanijesu Olalekan, Bamidele Abiodun, Daniel Adewole Adediran, Oluwaseun Adeola Obideyi, Seun Elijah Olufemi, Ahmad Mohammad Salamatullah, Mohammed Bourhia, Youssouf Ali Younous, Temitope Isaac Adelusi   +14 more
doaj   +1 more source

HIV Broadly Neutralizing Antibodies For Treatment, Prevention and Vaccine Design

Science Translational Medicine, 2019
Potent broadly neutralizing antibodies may be used to treat or prevent HIV and to help guide HIV vaccine design. Potent broadly neutralizing antibodies may be used to treat or prevent HIV and to help guide HIV vaccine design.
B. Haynes, D. Burton, J. Mascola
semanticscholar   +1 more source

Using simulation to estimate the power of a badger vaccine trial [PDF]

, 2011
The aim of this study was to estimate the power of a badger vaccine field trial using simulation techniques. The effects of sample size, sensitivity and specificity of the diagnostic test, transmission rate between unvaccinated badgers, Vaccine Efficacy ...
Aznar, I., More, S.J., Jong, M.C.M., de, Frankena, K.   +3 more
core  

Evidence of blood stage efficacy with a virosomal malaria vaccine in a Phase IIa clinical trial [PDF]

, 2008
Background Previous research indicates that a combination vaccine targeting different stages of the malaria life cycle is likely to provide the most effective malaria vaccine.
Gerd Pluschke, Sarah C. Gilbert, Hill, Adrian, Hutchings, Claire, Gilbert Sarah C., Sinden, Robert, Gilbert, Sarah C., Zurbriggen Rinaldo, Vogel, Denise, Jack L. Williams, Andrews Laura, Westerfeld Nicole, Andrews, Laura, David W. Porter, Thompson, Fiona, Okitsu, Shinji, Ian Poulton, Shinji L. Okitsu, Denise Vogel, Dunachie Susanna, Thompson Fiona M., Berthoud, Tamara, Porter David W., Pluschke, Gerd, Sarah C Gilbert, Sinden Robert, Poulton Ian, Fiona M Thompson, Zurbriggen, Rinaldo, Rinaldo Zurbriggen, Susanna Dunachie, Westerfeld, Nicole, Tamara Berthoud, Todryk, Stephen, Okitsu Shinji L., Hill Adrian V. S., Correa Simon, Berthoud Tamara, David W Porter, Nicole Westerfeld, Todryk Stephen, Porter, David, Correa, Simon, Pluschke Gerd, Poulton, Ian, Hutchings Claire, Vogel Denise, Shinji L Okitsu, Fiona M. Thompson, Jack L Williams, Simon Correa, Laura Andrews, Dunachie, Susanna, Adrian V S Hill, Robert Sinden, Stephen Todryk, Williams, Jack, Claire Hutchings, Williams Jack L., Thompson, Fiona M., Williams, Jack L., Porter, David W., Okitsu, Shinji L., Hill, Adrian V. S.   +63 more
core   +1 more source

BCG vaccination potentiates oxidative phosphorylation in neonatal myeloid‐derived suppressor cells

FEBS Open Bio, EarlyView.
BCG vaccination enhances oxidative phosphorylation in neonatal MDSCs, impairing their immunosuppressive function. It upregulates electron transport chain genes and mitochondrial activity, increasing ATP and oxygen consumption. Pharmacological OXPHOS inhibition partially restores suppressive capacity, confirming causality.
Yingying Chen, Hui Li
wiley   +1 more source

Glycoconjugate vaccines: current approaches towards faster vaccine design

Expert Review of Vaccines, 2019
Introduction: Over the last decades, glycoconjugate vaccines have been proven to be a successful strategy to prevent infectious diseases. Many diseases remain to be controlled, especially in developing countries, and emerging antibiotic-resistant ...
F. Micoli, Linda del Bino, R. Alfini, F. Carboni, M. Romano, R. Adamo   +5 more
semanticscholar   +1 more source